5-Benzyloxytryptamine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
5-Benzyloxytryptamine
5-benzyloxytryptamine.png
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ECHA InfoCard 100.040.007
Chemical and physical data
Formula C17H18N2O
Molar mass 266.34 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

5-Benzyloxytryptamine (5-BT), is a tryptamine derivative which acts as an agonist at the 5-HT1D, 5-HT2 and 5-HT6 serotonin receptors.[1][2][3][4]

See also[edit]

References[edit]

  1. ^ Lyon RA, Titeler M, Seggel MR, Glennon RA (January 1988). "Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens". European Journal of Pharmacology. 145 (3): 291–7. PMID 3350047. doi:10.1016/0014-2999(88)90432-3. 
  2. ^ Peroutka SJ, McCarthy BG, Guan XM (1991). "5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agent". Life Sciences. 49 (6): 409–18. PMID 1650872. doi:10.1016/0024-3205(91)90582-V. 
  3. ^ Cohen ML, Schenck K, Nelson D, Robertson DW (January 1992). "Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veins". European Journal of Pharmacology. 211 (1): 43–6. PMID 1319907. doi:10.1016/0014-2999(92)90260-B. 
  4. ^ Boess FG, Monsma FJ, Carolo C, Meyer V, Rudler A, Zwingelstein C, Sleight AJ (1997). "Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells". Neuropharmacology. 36 (4–5): 713–20. PMID 9225298. doi:10.1016/S0028-3908(97)00019-1.